Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig

Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig

Pokaži ostale verzije (1)

The type and genomic context of cancer mutations depend on their causes. These causes have been characterized using signatures that represent mutation types that co-occur in the same tumours. However, it remains unclear how mutation processes change during cancer evolution due to the lack of reliabl...

Bibliografski detalji
Glavni autori:	Rubanova, Y, Shi, R, Harrigan, CF, Li, R, Wintersinger, J, Sahin, N, Deshwar, A, PCAWG Evolution and Heterogeneity Working Group, Morris, Q, PCAWG Consortium
Daljnji autori:	Wedge, DC
Format:	Journal article
Jezik:	English
Izdano:	Springer Nature 2020

Slični predmeti

Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
od: Yulia Rubanova, i dr.
Izdano: (2020-02-01)

Author Correction: Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
od: Yulia Rubanova, i dr.
Izdano: (2022-12-01)

Inferring structural variant cancer cell fraction
od: Cmero, M, i dr.
Izdano: (2020)

Author Correction: Inferring structural variant cancer cell fraction
od: Marek Cmero, i dr.
Izdano: (2022-12-01)

Inferring structural variant cancer cell fraction
od: Marek Cmero, i dr.
Izdano: (2020-02-01)

Combined burden and functional impact tests for cancer driver discovery using DriverPower
od: Shimin Shuai, i dr.
Izdano: (2020-02-01)

The evolutionary history of 2,658 cancers
od: Gerstung, M, i dr.
Izdano: (2020)

Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower
od: Shimin Shuai, i dr.
Izdano: (2022-12-01)

Neutral tumor evolution?
od: Tarabichi, M, i dr.
Izdano: (2018)

Author Correction: High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations
od: Yiqun Zhang, i dr.
Izdano: (2022-12-01)

Author Correction: Integrative pathway enrichment analysis of multivariate omics data
od: Marta Paczkowska, i dr.
Izdano: (2022-12-01)

Integrative pathway enrichment analysis of multivariate omics data
od: Marta Paczkowska, i dr.
Izdano: (2020-02-01)

Author Correction: Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis
od: Joana Carlevaro-Fita, i dr.
Izdano: (2022-12-01)

A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
od: Jiao, W, i dr.
Izdano: (2020)

Sex differences in oncogenic mutational processes
od: Constance H. Li, i dr.
Izdano: (2020-08-01)

A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
od: Wei Jiao, i dr.
Izdano: (2020-02-01)

Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
od: Wei Jiao, i dr.
Izdano: (2022-12-01)

Reconstructing tumor evolutionary histories and clone trees in polynomial-time with SubMARine.
od: Linda K Sundermann, i dr.
Izdano: (2021-01-01)

Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours
od: Vinayak Bhandari, i dr.
Izdano: (2022-12-01)

Divergent mutational processes distinguish hypoxic and normoxic tumours
od: Vinayak Bhandari, i dr.
Izdano: (2020-02-01)

Guidelines for using sigQC for systematic evaluation of gene signatures
od: Dhawan, A, i dr.
Izdano: (2019)

Sig-Networks toolkit: signature networks for longitudinal language modelling
od: Tseriotou, T, i dr.
Izdano: (2023)

Sig-networks toolkit: signature networks for longitudinal language modelling
od: Tseriotou, T, i dr.
Izdano: (2024)

ImageSig: a signature transform for ultra-lightweight image recognition
od: Ibrahim, MR, i dr.
Izdano: (2022)

Regional mutational signature activities in cancer genomes.
od: Caitlin Timmons, i dr.
Izdano: (2022-12-01)

Genomic signatures from bench to bedside - a protocol for translation: sigQC
od: Dhawan, A, i dr.
Izdano: (2019)

Using sigLASSO to optimize cancer mutation signatures jointly with sampling likelihood
od: Shantao Li, i dr.
Izdano: (2020-07-01)

Author Correction: Genomic footprints of activated telomere maintenance mechanisms in cancer
od: Lina Sieverling, i dr.
Izdano: (2022-12-01)

Genomic footprints of activated telomere maintenance mechanisms in cancer
od: Lina Sieverling, i dr.
Izdano: (2020-02-01)

Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
od: Matthew H. Bailey, i dr.
Izdano: (2020-09-01)

Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
od: Matthew H. Bailey, i dr.
Izdano: (2020-11-01)

Att läsa sig in och skriva sig ut
od: Jenny Ingridsdotter
Izdano: (2017-09-01)

ChromaSig: a probabilistic approach to finding common chromatin signatures in the human genome.
od: Gary Hon, i dr.
Izdano: (2008-10-01)

DrugSig: A resource for computational drug repositioning utilizing gene expression signatures.
od: Hongyu Wu, i dr.
Izdano: (2017-01-01)

High-order epistasis shapes evolutionary trajectories.
od: Zachary R Sailer, i dr.
Izdano: (2017-05-01)

Social and sustainable entrepreneurship track by the EURAM SIG Entrepreneurship
od: Marzena Starnawska
Izdano: (2021-12-01)

Herramientas SIG 3D
od: Francisco R. Feito Higueruela, i dr.
Izdano: (2010-04-01)

Reconstructing cancer phylogenies using Pairtree, a clone tree reconstruction algorithm
od: Ethan Kulman, i dr.
Izdano: (2022-12-01)

Compact software/hardware co-design and implementation method of Aigis-sig digital signature scheme
od: Zhen ZHOU, i dr.
Izdano: (2021-04-01)

SigWinR; the SigWin-detector updated and ported to R
od: Breit Timo M, i dr.
Izdano: (2009-10-01)